EFFECT OF CHEWING GUM ON CONTROLLING NAUSEA/VOMITING AND THIRST IN PATIENTS WITH ACUTE PANCREATITIS

February 2, 2024 updated by: Özlem Ceyhan, TC Erciyes University

Erciyes University

Nausea and vomiting are one of the most common symptoms in acute pancreatitis. In addition to pharmacological methods for nausea and vomiting, non-pharmacological methods can also be used. Among these, anticipatory nausea and vomiting can be prevented by behaviors aimed at distracting attention. This study will be conducted to evaluate the effect of chewing gum on the severity of nausea-vomiting and thirst in patients with acute pancreatitis. The study will be conducted with a total of 60 patients, 30 intervention and 30 control.

Patients in the intervention group will chew xylitol gum five times a day for three days. The patients' thirst and nausea and vomiting conditions will be examined.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Kayseri, Turkey, 38039
        • Recruiting
        • Erciyes University Hospital
        • Contact:
          • Özlem Ceyhan, Assoc.Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Those diagnosed with acute pancreatitis,

    • Without total dental prosthesis,
    • Without salivary gland infection,
    • Those who have not had salivary gland surgery,
    • No difficulty in chewing,
    • Not receiving oxygen therapy,
    • Able to answer all questions and be communicativ

Exclusion Criteria:

  • Those with diabetes,
  • Does not like chewing gum,
  • Receiving radiotherapy or chemotherapy,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: intervention group
Other: Gum group
Group chewing gum with xylitol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thirst Severity -Visual Analog Scale
Time Frame: Apply in the morning of the 1st day after application
Visual Analog Scale is a 10 cm long scale that evaluates the severity of thirst.
Apply in the morning of the 1st day after application

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rhodes Nausea, Vomiting and Retching Index
Time Frame: Apply in the morning of the 1st day after application
It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.
Apply in the morning of the 1st day after application
Rhodes Nausea, Vomiting and Retching Index (
Time Frame: Apply in the morning of the 1st day after application
It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.
Apply in the morning of the 1st day after application

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

TC Erciyes University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Actual)

February 1, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

October 5, 2023

First Submitted That Met QC Criteria

October 5, 2023

First Posted (Actual)

October 11, 2023

Study Record Updates

Last Update Posted (Estimated)

February 5, 2024

Last Update Submitted That Met QC Criteria

February 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Thirstgum

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis

Clinical Trials on Gum group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe